NeuroPointDX, the diagnostics division of Stemina Biomarker Discover, has validated a first-generation autism diagnostic blood test panel in its Children’s Autism Metabolome Project (CAMP) clinical study, the organization announced recently….

NeuroPointDX, the diagnostics division of Stemina Biomarker Discovery, and New York-based Ovid Therapeutics announced today they will team up to identify novel biomarkers of a rare genetic disorder called Angelman syndrome….